Global network of dedicated and strategically located high enrolling Phase 1 - 3 international clinical trial investigative sites, operating under the maxim Experience-Integrity-Quality.

Long-term exclusivity agreements with globally located prominent teaching hospitals and clinics to operate and manage state-of-the-art clinical investigative sites having extensive experience in conducting drug development clinical trials according to ICH Good Clinical Practice Guidelines.

High-performance international investigative sites encompass a multi-million, diverse ethnic catchment area population, with preferred access to a fast-growing, highly compliant local clinical trial subject populace. Independently audited and qualified, a number of our clinical facilities are recipients of the prestigious "Best Clinical Trial Site" recognition. Primarily focused on conducting Phase 2 and Phase 3 drug development clinical trials, our sites have very low screen-failure and excellent patient retention rates. Clinical facilities are directly operated and managed by Completum Clinical partner-provider team members who have in-depth knowledge and hands-on experience in the management of successful North American clinical trial investigative sites.

State-of-the-art Phase 1 Study Clinics in California, New York, and Asia.